Skip to the page

Data / Drug companies / Elite Laboratories, Inc.

Elite Laboratories, Inc.: 53 products in the FDA NDC directory, labeler code 64850

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Elite Laboratories, Inc. (labeler code 64850) lists 53 products in the FDA National Drug Code Directory, covering 14 finished drugs by generic name. By type: 53 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 10, 2025.

The request: Watch Elite Laboratories, Inc. (FDA labeler code 64850): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
64850
Products in commercial distribution
53
Packages
81
Finished drugs by generic name
14
Prescription products
53
Over the counter products
0
Controlled substance products
Schedule II 30, Schedule III 3, Schedule IV 1
Flagged as original packager
53 of 53 products that carry the flag
Started marketing in the last 12 months
5
Earliest marketing start
October 26, 2005
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)53100%

Products by type

TypeProductsShare
Prescription drugs53100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet2241.5%
Capsule1935.8%
Capsule, extended release611.3%
Tablet, extended release59.4%
Tablet, film coated11.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ropinirole64850-254Tablet, extended releaseGeneric drugs (ANDA)November 10, 2025
Ropinirole64850-253Tablet, extended releaseGeneric drugs (ANDA)November 10, 2025
Ropinirole64850-252Tablet, extended releaseGeneric drugs (ANDA)November 10, 2025
Ropinirole64850-251Tablet, extended releaseGeneric drugs (ANDA)November 10, 2025
Ropinirole64850-250Tablet, extended releaseGeneric drugs (ANDA)November 10, 2025
Naltrexone Hydrochloride64850-300Tablet, film coatedGeneric drugs (ANDA)August 15, 2025
Lisdexamfetamine Dimesylate64850-556CapsuleGeneric drugs (ANDA)November 15, 2024
Lisdexamfetamine Dimesylate64850-555CapsuleGeneric drugs (ANDA)November 15, 2024
Lisdexamfetamine Dimesylate64850-554CapsuleGeneric drugs (ANDA)November 15, 2024
Lisdexamfetamine Dimesylate64850-553CapsuleGeneric drugs (ANDA)November 15, 2024
Lisdexamfetamine Dimesylate64850-552CapsuleGeneric drugs (ANDA)November 15, 2024
Lisdexamfetamine Dimesylate64850-551CapsuleGeneric drugs (ANDA)November 15, 2024
Lisdexamfetamine Dimesylate64850-550CapsuleGeneric drugs (ANDA)November 15, 2024
Methotrexate Sodium64850-330TabletGeneric drugs (ANDA)May 16, 2024
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate64850-506TabletGeneric drugs (ANDA)December 29, 2022
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate64850-505TabletGeneric drugs (ANDA)December 29, 2022
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate64850-504TabletGeneric drugs (ANDA)December 29, 2022
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate64850-503TabletGeneric drugs (ANDA)December 29, 2022
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate64850-502TabletGeneric drugs (ANDA)December 29, 2022
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate64850-501TabletGeneric drugs (ANDA)December 29, 2022
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate64850-500TabletGeneric drugs (ANDA)December 29, 2022
Isradipine64850-911CapsuleGeneric drugs (ANDA)December 28, 2022
Isradipine64850-910CapsuleGeneric drugs (ANDA)December 28, 2022
Loxapine64850-893CapsuleGeneric drugs (ANDA)January 27, 2020
Loxapine64850-892CapsuleGeneric drugs (ANDA)January 27, 2020

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.